Phase I clinical trial with ametantrone (NSC-287513). 1981

M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1985, Investigational new drugs,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1975, Cancer chemotherapy reports,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1975, Cancer chemotherapy reports,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
October 1994, Anti-cancer drugs,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
November 1983, Cancer treatment reports,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1976, Cancer treatment reports,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1980, Cancer clinical trials,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1987, Cancer chemotherapy and pharmacology,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
January 1975, Cancer chemotherapy reports,
M Piccart, and M Rozencweig, and R Abele, and E Cumps, and P Dodion, and D Dupont, and D Kisner, and Y Kenis
October 1974, Cancer,
Copied contents to your clipboard!